Latest news

New Poll: Bipartisan Majority Believes Medicare Beneficiaries Should Have Access to FDA-approved Early Alzheimer's Medications the Same Way They Do for All Other Diseases
American voters are willing to pay more to ensure access and want Congress to step in if Medicare continues restricting access to Alzheimer's treatments.   WASHINGTON, DC / ACCESSWIRE / October 10, 2024 / More than four in five voters (82%) favor requiring Medicare and other
Press release
Oct 10,2024
Chronic Disease Patient Groups Call on Congress to Protect Small Molecule Medicine Access and Innovation
September 13, 2024 (Washington, DC) The Partnership to Fight Chronic Disease (PFCD) released the following statement upon delivery of a sign on letter to Congress from more than 30 patient and consumer advocacy groups calling for support of the bipartisan Ensuring Pathways to Innovative Cures (EPIC
Press release
Sep 12,2024
CHRONIC DISEASE COMPLICATES POSTPARTUM HEALTH AMONG BLACK WOMEN
SAN DIEGO, CA – On September 4th, the Partnership to Fight Chronic Disease (PFCD) will host an event in collaboration with California State Assemblymember Dr. Akilah Weber, focusing on the physical and mental health needs of Black women as they navigate the postpartum period. The event will
Press release
Aug 28,2024
PARTNERSHIP TO FIGHT CHRONIC DISEASE RESPONSE TO MEDICARE DRUG PRICE ANNOUNCEMENT
IRA’s “negotiated” prices represent much #MoreThanAList when considering access impacts and lack of savings for millions of chronic disease patients   August 15, 2024 (WASHINGTON, DC) The Partnership to Fight Chronic Disease (PFCD) today released the following statement in
Press release
Aug 15,2024
NEW DATA ILLUSTRATE HUMAN IMPACTS OF FEWER TREATMENTS RESULTING FROM INFLATION REDUCTION ACT’S PRICE CONTROLS
Case studies highlight peril to treatment advances across several disease states   August 14, 2024 (WASHINGTON, DC) The Partnership to Fight Chronic Disease (PFCD) today announced the release of a new data set that highlights critical risks posed to the development and delivery of new
Press release
Aug 14,2024
PFCD APPLAUDS FDA APPROVAL FOR NEW ALZHEIMER’S TREATMENT
Ensuring access and coverage remains a top priority   July 3, 2024 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement in response to the U.S. Food and Drug Administration (FDA) traditional approval of KisunlaTM (donanemab), a therapy developed
Press release
Jul 3,2024
Prescription Drug Affordability Board might not deliver savings to patients
By Hannah Pfeiffer and Candace DeMatteis June 5, 2024 Boulder Daily Camera   A group of unelected state officials is pondering a decision with enormous consequences for thousands of Colorado patients battling chronic diseases. In 2021, Colorado established a Prescription Drug
OP-ED
Jun 5,2024
By Tweaking the IRA, This Legislation Could Save Lives
May 1, 2024    The impact of the Inflation Reduction Act on the price of medicine is starting to play out. Measures to cap the price of insulin at $35 a month for Medicare enrollees took effect on Jan. 1.   In 2025, the IRA will cap annual out-of-pocket prescription drug costs
In the news
May 4,2024
New Insurer Perspectives Highlight Considerable Patient Challenges Anticipated from Prescription Drug Affordability Boards
April 2, 2024 (Washington, DC) Today the Partnership to Fight Chronic Disease (PFCD) released a new white paper, “Health Plans Predict: Implementing Upper Payment Limits May Alter Formularies and Benefit Design But Won’t Reduce Patient Costs,” which details feedback from
Press release
Apr 2,2024
BIDEN ADMINISTRATION STATE OF THE UNION HIGHLIGHTS MISGUIDED PROPOSAL TO EXPAND THE INFLATION REDUCTION ACT
Unintended consequences for chronic disease patients are many   March 8, 2024 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) today released the following statement from Chair Ken Thorpe in response to President Biden’s State of the Union address:   “
Press release
Mar 8,2024

Pages